ABCL
Price:
$2.39
Market Cap:
$704.25M
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.[Read more]
Industry
Biotechnology
IPO Date
2020-12-11
Stock Exchange
NASDAQ
Ticker
ABCL
According to AbCellera Biologics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.51. This represents a change of -46.87% compared to the average of -8.49 of the last 4 quarters.
The mean historical PE Ratio of AbCellera Biologics Inc. over the last ten years is 5.96K. The current -4.51 PE Ratio has changed -107.57% with respect to the historical average. Over the past ten years (40 quarters), ABCL's PE Ratio was at its highest in in the September 2019 quarter at 64.87K. The PE Ratio was at its lowest in in the March 2019 quarter at -7344.14.
Average
5.96K
Median
18.22
Minimum
-3750.57
Maximum
45.31K
Discovering the peaks and valleys of AbCellera Biologics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual PE Ratio = 45.31K
Minimum Annual Increase = -161.91%
Minimum Annual PE Ratio = -3750.57
Year | PE Ratio | Change |
---|---|---|
2023 | -11.28 | -161.91% |
2022 | 18.22 | -29.11% |
2021 | 25.70 | -71.82% |
2020 | 91.19 | -102.43% |
2019 | -3750.57 | -108.28% |
2018 | 45.31K | Infinity% |
The current PE Ratio of AbCellera Biologics Inc. (ABCL) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
10.88
5-year avg
-725.35
10-year avg
5.96K
AbCellera Biologics Inc.’s PE Ratio is less than CohBar, Inc. (-0.20), less than Hepion Pharmaceuticals, Inc. (-0.15), less than Rain Therapeutics Inc. (-0.62), less than Krystal Biotech, Inc. (49.72), less than AVROBIO, Inc. (2.07), less than CureVac N.V. (-2.00), greater than Reata Pharmaceuticals, Inc. (-89.36), less than Vir Biotechnology, Inc. (-2.19), less than Propanc Biopharma, Inc. (-0.01), greater than PTC Therapeutics, Inc. (-5.05), less than Sarepta Therapeutics, Inc. (257.91), greater than Iovance Biotherapeutics, Inc. (-6.48), greater than Madrigal Pharmaceuticals, Inc. (-10.23),
Company | PE Ratio | Market cap |
---|---|---|
-0.20 | $1.25M | |
-0.15 | $4.20M | |
-0.62 | $44.01M | |
49.72 | $5.29B | |
2.07 | $5.24M | |
-2.00 | $614.60M | |
-89.36 | $6.57B | |
-2.19 | $1.06B | |
-0.01 | $278.87K | |
-5.05 | $2.43B | |
257.91 | $12.29B | |
-6.48 | $3.04B | |
-10.23 | $5.30B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbCellera Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbCellera Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AbCellera Biologics Inc.'s PE Ratio?
How is the PE Ratio calculated for AbCellera Biologics Inc. (ABCL)?
What is the highest PE Ratio for AbCellera Biologics Inc. (ABCL)?
What is the 3-year average PE Ratio for AbCellera Biologics Inc. (ABCL)?
What is the 5-year average PE Ratio for AbCellera Biologics Inc. (ABCL)?
How does the current PE Ratio for AbCellera Biologics Inc. (ABCL) compare to its historical average?